Licht JD - Search Results

1

The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.

Bennett RL, Swaroop A, Troche C, Licht JD. Bennett RL, et al. Among authors: licht jd. Cold Spring Harb Perspect Med. 2017 Jun 1;7(6):a026708. doi: 10.1101/cshperspect.a026708. Cold Spring Harb Perspect Med. 2017. PMID: 28193767 Free PMC article. Review.

2

Sabotaging of the oxidative stress response by an oncogenic noncoding RNA.

Mahajan N, Wu HJ, Bennett RL, Troche C, Licht JD, Weber JD, Maggi LB Jr, Tomasson MH. Mahajan N, et al. Among authors: licht jd. FASEB J. 2017 Feb;31(2):482-490. doi: 10.1096/fj.201600654R. Epub 2016 Oct 24. FASEB J. 2017. PMID: 28148777 Free PMC article.

3

Epigenetic regulatory mutations and epigenetic therapy for multiple myeloma.

Dupéré-Richer D, Licht JD. Dupéré-Richer D, et al. Among authors: licht jd. Curr Opin Hematol. 2017 Jul;24(4):336-344. doi: 10.1097/MOH.0000000000000358. Curr Opin Hematol. 2017. PMID: 28441149 Free PMC article. Review.

4

Targeting Epigenetics in Cancer.

Bennett RL, Licht JD. Bennett RL, et al. Among authors: licht jd. Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:187-207. doi: 10.1146/annurev-pharmtox-010716-105106. Epub 2017 Oct 6. Annu Rev Pharmacol Toxicol. 2018. PMID: 28992434 Free PMC article. Review.

5

SETD2: a complex role in blood malignancy.

Licht JD. Licht JD. Blood. 2017 Dec 14;130(24):2576-2578. doi: 10.1182/blood-2017-10-811927. Blood. 2017. PMID: 29242204 Free PMC article.

6

DISORDERED HISTONE METHYLATION IN HEMATOLOGICAL MALIGNANCIES THE CASE OF UTX/KDM6A.

Licht JD. Licht JD. Trans Am Clin Climatol Assoc. 2018;129:24-36. Trans Am Clin Climatol Assoc. 2018. PMID: 30166694 Free PMC article.

7

An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.

Swaroop A, Oyer JA, Will CM, Huang X, Yu W, Troche C, Bulic M, Durham BH, Wen QJ, Crispino JD, MacKerell AD Jr, Bennett RL, Kelleher NL, Licht JD. Swaroop A, et al. Among authors: licht jd. Oncogene. 2019 Jan;38(5):671-686. doi: 10.1038/s41388-018-0474-y. Epub 2018 Aug 31. Oncogene. 2019. PMID: 30171259 Free PMC article.

8

Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.

Huang X, LeDuc RD, Fornelli L, Schunter AJ, Bennett RL, Kelleher NL, Licht JD. Huang X, et al. Among authors: licht jd. J Biol Chem. 2019 Aug 16;294(33):12459-12471. doi: 10.1074/jbc.RA118.006159. Epub 2019 Jun 27. J Biol Chem. 2019. PMID: 31248990 Free PMC article.

9

A Mutation in Histone H2B Represents a New Class of Oncogenic Driver.

Bennett RL, Bele A, Small EC, Will CM, Nabet B, Oyer JA, Huang X, Ghosh RP, Grzybowski AT, Yu T, Zhang Q, Riva A, Lele TP, Schatz GC, Kelleher NL, Ruthenburg AJ, Liphardt J, Licht JD. Bennett RL, et al. Among authors: licht jd. Cancer Discov. 2019 Oct;9(10):1438-1451. doi: 10.1158/2159-8290.CD-19-0393. Epub 2019 Jul 23. Cancer Discov. 2019. PMID: 31337617 Free PMC article.

10

Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myeloma.

Cheong CM, Mrozik KM, Hewett DR, Bell E, Panagopoulos V, Noll JE, Licht JD, Gronthos S, Zannettino ACW, Vandyke K. Cheong CM, et al. Among authors: licht jd. Cancer Lett. 2020 Apr 10;475:99-108. doi: 10.1016/j.canlet.2020.01.040. Epub 2020 Jan 31. Cancer Lett. 2020. PMID: 32014459 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters